Heparin prevents recurrent VTE in cancer patients

Affiliations

Comment

Timothy L Clenney et al. J Fam Pract. 2003 Nov.

. 2003 Nov;52(11):843-4.

¹ Department of Family Medicine, Naval Hospital Jacksonville, Jacksonville, FL, USA. tclenney@msn.com

No abstract available

Comment on

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, Gent M; Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators. Lee AY, et al. N Engl J Med. 2003 Jul 10;349(2):146-53. doi: 10.1056/NEJMoa025313. N Engl J Med. 2003. PMID: 12853587 Clinical Trial.